Fieldfisher advised Complement Therapeutics on the deal.Complement Therapeutics Ltd (CTx), a preclinical stage University of Manchester spinout, raised €5 million through a seed financing round from BioGeneration…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
